© 2000 American Heart Association, Inc.
Molecular Medicine |
Development of a Smooth Muscle–Targeted Cre Recombinase Mouse Reveals Novel Insights Regarding Smooth Muscle Myosin Heavy Chain Promoter Regulation
From the Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, Va. C.P.R.’s present address is Department of Genomic Pharmacology, Vertex Pharmaceuticals, Cambridge, Mass.
Correspondence to Gary K. Owens, PhD, Department of Molecular Physiology and Biological Physics, 1300 Jefferson Park Ave, PO Box 800736, Charlottesville, VA 22908. E-mail gko{at}virginia.edu
Abstract—The use of genetically modified mice has been an important model system to study gene function in cardiovascular development and under pathophysiological conditions. Although conventional gene knockout studies have provided important insights into gene function in the cardiovascular system, they may be limited by upregulation of compensatory pathways and the inability to differentiate direct versus indirect functions in vivo. As a first step in developing systems that can target gene activation or inactivation specifically to smooth muscle cells (SMCs), we coupled the smooth muscle myosin heavy chain (SMMHC) promoter to the cre recombinase gene and generated transgenic mice that express cre in SMCs. In addition, we used these mice to address whether the heterogeneous staining observed in SMMHC-LacZ mice was due to subsets of SMCs that required different regulatory cassettes of the promoter or if it reflected episodic expression of the transgene. To address both the feasibility of SMC targeting and the apparent heterogeneous expression, we bred SMMHC-cre mice to indicator mice containing a cre-activated LacZ gene. Results showed high-level expression in SMCs at various embryonic time points and in adult tissues. Because breeding of SMMHC-cre mice to an indicator line provided an integration of cre activity over time, results of this study revealed that expression of the SMMHC promoter fragment more closely resembled the expression of the endogenous gene, both with respect to the onset of activation during development and uniformity of staining among individual cells within tissues. Overall, these mice will provide a powerful tool to researchers to study gene function in vascular development/disease by using cre/lox technology to direct smooth muscle–specific gene activation or inactivation in vivo.
Key Words: cre recombinase • smooth muscle myosin heavy chain • cardiovascular development • gene targeting • vascular biology
This article has been cited by other articles:
 |
|
 |
|
  D. E. Michele, Z. Kabaeva, S. L. Davis, R. M. Weiss, and K. P. Campbell Dystroglycan Matrix Receptor Function in Cardiac Myocytes Is Important for Limiting Activity-Induced Myocardial Damage Circ. Res., November 6, 2009; 105(10): 984 - 993. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Y. Lounev, R. Ramachandran, M. N. Wosczyna, M. Yamamoto, A. D.A. Maidment, E. M. Shore, D. L. Glaser, D. J. Goldhamer, and F. S. Kaplan Identification of Progenitor Cells That Contribute to Heterotopic Skeletogenesis J. Bone Joint Surg. Am., March 1, 2009; 91(3): 652 - 663. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. J. de Lange, C. M. Halabi, A. M. Beyer, and C. D. Sigmund Germ line activation of the Tie2 and SMMHC promoters causes noncell-specific deletion of floxed alleles Physiol Genomics, September 17, 2008; 35(1): 1 - 4. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Doran, N. Meller, and C. A. McNamara Role of Smooth Muscle Cells in the Initiation and Early Progression of Atherosclerosis Arterioscler Thromb Vasc Biol, May 1, 2008; 28(5): 812 - 819. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Frutkin, H. Shi, G. Otsuka, and D. A. Dichek Targeted Rearrangement of Floxed Alleles in Smooth Muscle Cells in Vivo Circ. Res., December 7, 2007; 101(12): e124 - e125. [Full Text] [PDF]
|
|
|
|
|
|
Y. Liao, C. P. Regan, I. Manabe, G. K. Owens, K. H. Day, D. N. Damon, and B. R. Duling Smooth Muscle-Targeted Knockout of Connexin43 Enhances Neointimal Formation in Response to Vascular Injury Arterioscler Thromb Vasc Biol, May 1, 2007; 27(5): 1037 - 1042. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Zhang, W. Zhong, T. Cui, M. Yang, X. Hu, K. Xu, C. Xie, C. Xue, G. H. Gibbons, C. Liu, et al. Generation of an Adult Smooth Muscle Cell-Targeted Cre Recombinase Mouse Model Arterioscler Thromb Vasc Biol, March 1, 2006; 26(3): e23 - e24. [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Burckle, A.H. Jan Danser, D. N. Muller, I. M. Garrelds, J.-M. Gasc, E. Popova, R. Plehm, J. Peters, M. Bader, and G. Nguyen Elevated Blood Pressure and Heart Rate in Human Renin Receptor Transgenic Rats Hypertension, March 1, 2006; 47(3): 552 - 556. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Dikalova, R. Clempus, B. Lassegue, G. Cheng, J. McCoy, S. Dikalov, A. S. Martin, A. Lyle, D. S. Weber, D. Weiss, et al. Nox1 Overexpression Potentiates Angiotensin II-Induced Hypertension and Vascular Smooth Muscle Hypertrophy in Transgenic Mice Circulation, October 25, 2005; 112(17): 2668 - 2676. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Handa, M. A. Momen, A.-M. Sadi, T. Afroze, C. Wang, and M. Husain Troubles With a Transgene: Experiences With SM22{alpha}-tTA Mice Circ. Res., October 14, 2005; 97(8): e85 - e87. [Full Text] [PDF]
|
|
|
|
|
|
T. Yoshida and G. K. Owens Molecular Determinants of Vascular Smooth Muscle Cell Diversity Circ. Res., February 18, 2005; 96(3): 280 - 291. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-B. Xin, K.-Y. Deng, B. Shui, S. Qu, Q. Sun, J. Lee, K. S. Greene, J. Wilson, Y. Yu, M. Feldman, et al. Gene trap and gene inversion methods for conditional gene inactivation in the mouse Nucleic Acids Res., January 19, 2005; 33(2): e14 - e14. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Miano, N. Ramanan, M. A. Georger, K. L. de Mesy Bentley, R. L. Emerson, R. O. Balza Jr., Q. Xiao, H. Weiler, D. D. Ginty, and R. P. Misra Restricted inactivation of serum response factor to the cardiovascular system PNAS, December 7, 2004; 101(49): 17132 - 17137. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Sinha, M. H. Hoofnagle, P. A. Kingston, M. E. McCanna, and G. K. Owens Transforming growth factor-{beta}1 signaling contributes to development of smooth muscle cells from embryonic stem cells Am J Physiol Cell Physiol, December 1, 2004; 287(6): C1560 - C1568. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. K. Owens, M. S. Kumar, and B. R. Wamhoff Molecular Regulation of Vascular Smooth Muscle Cell Differentiation in Development and Disease Physiol Rev, July 1, 2004; 84(3): 767 - 801. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Dandre and G. K. Owens Platelet-derived growth factor-BB and Ets-1 transcription factor negatively regulate transcription of multiple smooth muscle cell differentiation marker genes Am J Physiol Heart Circ Physiol, June 1, 2004; 286(6): H2042 - H2051. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Ji, M. E. Feldman, K.-Y. Deng, K. S. Greene, J. Wilson, J. C. Lee, R. C. Johnston, M. Rishniw, Y. Tallini, J. Zhang, et al. Ca2+-sensing Transgenic Mice: POSTSYNAPTIC SIGNALING IN SMOOTH MUSCLE J. Biol. Chem., May 14, 2004; 279(20): 21461 - 21468. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. Allende, T. Yamashita, and R. L. Proia G-protein-coupled receptor S1P1 acts within endothelial cells to regulate vascular maturation Blood, November 15, 2003; 102(10): 3665 - 3667. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Hoggatt, G. M. Simon, and B. P. Herring Cell-Specific Regulatory Modules Control Expression of Genes in Vascular and Visceral Smooth Muscle Tissues Circ. Res., December 13, 2002; 91(12): 1151 - 1159. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-B. Xin, K.-Y. Deng, M. Rishniw, G. Ji, and M. I. Kotlikoff Smooth muscle expression of Cre recombinase and eGFP in transgenic mice Physiol Genomics, September 3, 2002; 10(3): 211 - 215. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Holtwick, M. Gotthardt, B. Skryabin, M. Steinmetz, R. Potthast, B. Zetsche, R. E. Hammer, J. Herz, and M. Kuhn Smooth muscle-selective deletion of guanylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure PNAS, May 14, 2002; 99(10): 7142 - 7147. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Eckhart, T. Ozaki, H. Tevaearai, H. A. Rockman, and W. J. Koch Vascular-Targeted Overexpression of G Protein-Coupled Receptor Kinase-2 in Transgenic Mice Attenuates beta -Adrenergic Receptor Signaling and Increases Resting Blood Pressure Mol. Pharmacol., April 1, 2002; 61(4): 749 - 758. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Manabe and G. K. Owens The Smooth Muscle Myosin Heavy Chain Gene Exhibits Smooth Muscle Subtype-selective Modular Regulation in Vivo J. Biol. Chem., October 12, 2001; 276(42): 39076 - 39087. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Liao, K. H. Day, D. N. Damon, and B. R. Duling Endothelial cell-specific knockout of connexin 43 causes hypotension and bradycardia in mice PNAS, July 24, 2001; (2001) 171305298. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Liao, K. H. Day, D. N. Damon, and B. R. Duling Endothelial cell-specific knockout of connexin 43 causes hypotension and bradycardia in mice PNAS, August 14, 2001; 98(17): 9989 - 9994. [Abstract] [Full Text] [PDF]
|
|